Erin Elizabeth Coglianese, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 5 | 2024 | 3233 | 0.720 |
Why?
|
Heart Failure | 14 | 2024 | 11670 | 0.550 |
Why?
|
Receptors, Cell Surface | 5 | 2013 | 2822 | 0.400 |
Why?
|
Heart-Assist Devices | 5 | 2023 | 1287 | 0.380 |
Why?
|
Hematocrit | 1 | 2011 | 623 | 0.350 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2013 | 2118 | 0.240 |
Why?
|
Growth Differentiation Factor 15 | 3 | 2013 | 198 | 0.210 |
Why?
|
Patient Selection | 1 | 2015 | 4244 | 0.210 |
Why?
|
Natriuretic Peptide, Brain | 6 | 2022 | 1723 | 0.180 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2022 | 173 | 0.170 |
Why?
|
Puerperal Disorders | 1 | 2022 | 299 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 413 | 0.150 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2177 | 0.140 |
Why?
|
Aortic Valve Stenosis | 1 | 2009 | 2001 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2013 | 851 | 0.130 |
Why?
|
Fatigue | 1 | 2022 | 1552 | 0.130 |
Why?
|
Hemodynamics | 2 | 2022 | 4160 | 0.120 |
Why?
|
Tissue Donors | 2 | 2024 | 2332 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2024 | 992 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1039 | 0.110 |
Why?
|
Lung Transplantation | 1 | 2023 | 1310 | 0.110 |
Why?
|
Heart | 3 | 2023 | 4404 | 0.110 |
Why?
|
Mitral Valve | 1 | 2021 | 1465 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2024 | 1277 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1924 | 0.100 |
Why?
|
Laparoscopy | 1 | 2024 | 2036 | 0.100 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 1400 | 0.100 |
Why?
|
Echocardiography, Doppler | 2 | 2013 | 897 | 0.100 |
Why?
|
Troponin I | 2 | 2013 | 651 | 0.090 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15843 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2019 | 1032 | 0.090 |
Why?
|
Stroke Volume | 4 | 2022 | 5496 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1964 | 0.090 |
Why?
|
Systole | 1 | 2012 | 936 | 0.080 |
Why?
|
Diastole | 1 | 2012 | 782 | 0.080 |
Why?
|
Interleukins | 1 | 2013 | 782 | 0.080 |
Why?
|
Reference Values | 2 | 2012 | 4920 | 0.080 |
Why?
|
Elasticity Imaging Techniques | 1 | 2012 | 392 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2019 | 3060 | 0.070 |
Why?
|
C-Reactive Protein | 3 | 2013 | 3826 | 0.070 |
Why?
|
Proteomics | 1 | 2020 | 3848 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3358 | 0.070 |
Why?
|
Humans | 25 | 2024 | 761572 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2013 | 1403 | 0.070 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3879 | 0.070 |
Why?
|
Coronary Occlusion | 1 | 2009 | 304 | 0.060 |
Why?
|
Heart Atria | 1 | 2012 | 1345 | 0.060 |
Why?
|
Social Support | 1 | 2015 | 2171 | 0.060 |
Why?
|
Peptide Fragments | 2 | 2022 | 5112 | 0.060 |
Why?
|
Middle Aged | 14 | 2024 | 220920 | 0.050 |
Why?
|
Hypertension | 3 | 2012 | 8540 | 0.050 |
Why?
|
Fibroblast Growth Factors | 1 | 2009 | 867 | 0.050 |
Why?
|
Medication Adherence | 1 | 2015 | 2176 | 0.050 |
Why?
|
Risk Factors | 7 | 2024 | 74213 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8002 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2024 | 0.050 |
Why?
|
Body Mass Index | 3 | 2024 | 12954 | 0.050 |
Why?
|
Heart Rate | 1 | 2014 | 4195 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2024 | 282 | 0.050 |
Why?
|
Weight Loss | 2 | 2024 | 2684 | 0.050 |
Why?
|
Aged | 10 | 2024 | 169310 | 0.050 |
Why?
|
Sex Factors | 2 | 2012 | 10553 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2024 | 64684 | 0.050 |
Why?
|
Brain Death | 1 | 2024 | 357 | 0.050 |
Why?
|
Testosterone | 1 | 2012 | 2472 | 0.050 |
Why?
|
Coronary Disease | 2 | 2014 | 5914 | 0.050 |
Why?
|
Male | 15 | 2024 | 360842 | 0.050 |
Why?
|
Peripartum Period | 1 | 2022 | 137 | 0.050 |
Why?
|
Calcinosis | 1 | 2009 | 1469 | 0.040 |
Why?
|
Incidence | 2 | 2024 | 21355 | 0.040 |
Why?
|
Comorbidity | 2 | 2012 | 10508 | 0.040 |
Why?
|
Gastrectomy | 1 | 2024 | 672 | 0.040 |
Why?
|
Diuretics | 1 | 2022 | 610 | 0.040 |
Why?
|
Age Factors | 2 | 2012 | 18398 | 0.040 |
Why?
|
Female | 13 | 2024 | 392686 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2009 | 2091 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39107 | 0.040 |
Why?
|
Neprilysin | 1 | 2020 | 478 | 0.040 |
Why?
|
Pyrrolidines | 1 | 2019 | 338 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 15501 | 0.040 |
Why?
|
Quinoxalines | 1 | 2019 | 296 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 945 | 0.040 |
Why?
|
Prognosis | 3 | 2013 | 29629 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15266 | 0.040 |
Why?
|
Time Factors | 2 | 2024 | 39970 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2012 | 5841 | 0.030 |
Why?
|
Tissue and Organ Procurement | 1 | 2024 | 962 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2024 | 80646 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2013 | 5127 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2014 | 12463 | 0.030 |
Why?
|
Waiting Lists | 1 | 2019 | 765 | 0.030 |
Why?
|
Disease Progression | 1 | 2011 | 13510 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2019 | 858 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15936 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2022 | 1927 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2048 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2021 | 1462 | 0.030 |
Why?
|
Adult | 5 | 2024 | 221203 | 0.030 |
Why?
|
Hepacivirus | 1 | 2019 | 1336 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2013 | 321 | 0.020 |
Why?
|
Recovery of Function | 1 | 2022 | 2979 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2012 | 554 | 0.020 |
Why?
|
Prospective Studies | 2 | 2013 | 54426 | 0.020 |
Why?
|
Sampling Studies | 1 | 2011 | 615 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2012 | 713 | 0.020 |
Why?
|
Sulfonamides | 1 | 2019 | 1978 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2013 | 587 | 0.020 |
Why?
|
Kidney | 1 | 2024 | 7047 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1739 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 4989 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2012 | 836 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3792 | 0.020 |
Why?
|
Phosphates | 1 | 2009 | 770 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2009 | 1574 | 0.020 |
Why?
|
NF-kappa B | 1 | 2013 | 2490 | 0.010 |
Why?
|
Cohort Studies | 2 | 2022 | 41493 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4280 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2735 | 0.010 |
Why?
|
United States | 1 | 2011 | 72335 | 0.010 |
Why?
|
Models, Molecular | 1 | 2013 | 5439 | 0.010 |
Why?
|
Mortality | 1 | 2014 | 2901 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5790 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6344 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9646 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7581 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8830 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12059 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29876 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13255 | 0.010 |
Why?
|
Radiography | 1 | 2009 | 6965 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15732 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5972 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8481 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11904 | 0.010 |
Why?
|
Vitamin D | 1 | 2009 | 3303 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10212 | 0.010 |
Why?
|
Chronic Disease | 1 | 2009 | 9319 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 59255 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23996 | 0.010 |
Why?
|
Stroke | 1 | 2014 | 9758 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23447 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 26127 | 0.000 |
Why?
|
Obesity | 1 | 2009 | 12947 | 0.000 |
Why?
|